Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.71M 19.14M 17.6M 33.22M 2.28B 33.75M 229M 89.72M 1.11B 88.71M 86.78M 3.84B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.97M 34.18M 31.43M 59.31M 4.07B 60.26M 409M 160M 1.99B 158M 155M 6.86B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
Current month-14.63%
1 month-12.50%
3 months-16.67%
6 months-14.63%
Current year+6.06%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.81
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-46.97%+133.33% 1.33M
-5.95%-21.10%+16.57%+425.07% 2.22B
-0.57%-5.07% - - 1.89B
-0.56%-6.32%-41.83%-61.56% 1.63B
-4.35%-23.74%+79.08%+533.95% 1.36B
0.00%+3.86%-41.66%+40.07% 1.22B
+1.24%-0.14%+310.97%+920.45% 1.09B
+0.04%-0.75%+46.73%+20.55% 932M
-0.89%-14.11%+29.78%+45.26% 776M
+1.40%+0.47%-40.82%-90.62% 428M
Average -1.01%-6.37%+34.65%+218.50% 1.15B
Weighted average by Cap. -1.74%-8.36%+42.79%+273.12%

Financials

2015 2016
Net sales 25.48M 22.33M 20.64M 18.99M 35.83M 2.46B 36.4M 247M 96.77M 1.2B 95.68M 93.59M 4.14B 32.33M 28.34M 26.19M 24.09M 45.45M 3.12B 46.18M 313M 123M 1.53B 121M 119M 5.26B
Net income 5.49M 4.82M 4.45M 4.09M 7.73M 530M 7.85M 53.23M 20.87M 259M 20.63M 20.18M 893M 2.06M 1.81M 1.67M 1.54M 2.9M 199M 2.94M 19.97M 7.83M 97.25M 7.74M 7.57M 335M
Net Debt 24.8M 21.74M 20.1M 18.48M 34.87M 2.39B 35.43M 240M 94.2M 1.17B 93.14M 91.11M 4.03B 18.56M 16.27M 15.04M 13.83M 26.09M 1.79B 26.51M 180M 70.48M 876M 69.69M 68.17M 3.02B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
346
Date Price Change Volume
20/07/26 $0.003500 0.00% 126
  1. Stock Market
  2. Stocks
  3. AOXG Stock